A handful of proteins, detected in incredibly tiny amounts, may help doctors distinguish between a harmless lesion in the pancreas and a potentially deadly one. If confirmed, these biomarkers could represent reliable indicators of pancreatic cancer or precancerous pancreatic lesions, which would allow for earlier, perhaps more successful, treatments.